# Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder

> **NCT01372670** · PHASE4 · WITHDRAWN · sponsor: **HealthPartners Institute**

## Conditions studied

- Anxiety in Those Patients With Anorexia Nervosa
- Eating Disorder Not Otherwise Specified, BMI (<=18)

## Interventions

- **DRUG:** Hydroxyzine
- **DRUG:** hydroxyzine HCL
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01372670
- **Lead sponsor:** HealthPartners Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to unforseen recruiting difficulties, the study was closed.
- **Last updated:** 2016-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01372670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01372670, "Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01372670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*